Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model

<p>Abstract</p> <p>Background</p> <p>Twitcher mouse (<it>twi/twi</it>) is an authentic murine model of Krabbe's disease. Accumulation of psychosine, resulting in apoptosis of oligodendrocytes and subsequent demyelination, is a cardinal event to the path...

Full description

Bibliographic Details
Main Authors: Suzuki Kinuko, Fujitani Yasushi, Mohri Ikuko, Kagitani-Shimono Kuriko, Ozono Keiichi, Urade Yoshihiro, Taniike Masako
Format: Article
Language:English
Published: BMC 2005-04-01
Series:Journal of Neuroinflammation
Online Access:http://www.jneuroinflammation.com/content/2/1/10
_version_ 1828405715551649792
author Suzuki Kinuko
Fujitani Yasushi
Mohri Ikuko
Kagitani-Shimono Kuriko
Ozono Keiichi
Urade Yoshihiro
Taniike Masako
author_facet Suzuki Kinuko
Fujitani Yasushi
Mohri Ikuko
Kagitani-Shimono Kuriko
Ozono Keiichi
Urade Yoshihiro
Taniike Masako
author_sort Suzuki Kinuko
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Twitcher mouse (<it>twi/twi</it>) is an authentic murine model of Krabbe's disease. Accumulation of psychosine, resulting in apoptosis of oligodendrocytes and subsequent demyelination, is a cardinal event to the pathogenesis of this disease. Moreover, recruitment of inflammatory cells plays a significant role in the pathological process in the <it>twi/twi </it>central and peripheral nervous systems. In this study, we investigated the 1) the relationship between tumor necrosis factor-α (TNFα), pro-inflammatory cytokine, and the progression of this disease and 2) effect of the anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor.</p> <p>Methods</p> <p>We quantified the expression level of TNFα and TNF-receptor mRNA in <it>twi/twi </it>using semi-quantitative RT-PCR. The relationship between TNFα expression, apoptosis of oligodendrocytes and demyelination was studied with immunohistochemistry and TUNEL method. We then treated <it>twi/twi </it>with a daily intraperitoneal injection of ibudilast (10 mg/kg), which suppress TNFα production in the brain.</p> <p>Results</p> <p>We found that TNFα-immunoreactive microglia/macrophages appeared in the <it>twi/twi </it>brain and that the mRNA levels of TNFα and TNF-receptor 1 was increased with the progression of demyelination. The distribution profile of TNFα-immunoreactive microglia/macrophages overlapped that of TUNEL-positive oligodendrocytes in the <it>twi/twi </it>brain. When <it>twi/twi </it>was treated with ibudilast from PND30, the number of oligodendrocytes undergoing apoptosis was markedly reduced and demyelination was milder. Obvious improvement of clinical symptom was noted in two of five. The failure of constant clinical improvement by ibudilast may result from hepatotoxicity and/or the inhibition of proliferation of NG2-positive oligodendrocyte precursors.</p> <p>Conclusion</p> <p>We conclude that anti-inflammatory therapy by a phosphodiesterase inhibitor can be considered as a novel alternative therapy for Krabbe's disease.</p>
first_indexed 2024-12-10T10:58:09Z
format Article
id doaj.art-fc090cdf70b04b5bbd0058317a83fafb
institution Directory Open Access Journal
issn 1742-2094
language English
last_indexed 2024-12-10T10:58:09Z
publishDate 2005-04-01
publisher BMC
record_format Article
series Journal of Neuroinflammation
spelling doaj.art-fc090cdf70b04b5bbd0058317a83fafb2022-12-22T01:51:47ZengBMCJournal of Neuroinflammation1742-20942005-04-01211010.1186/1742-2094-2-10Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination modelSuzuki KinukoFujitani YasushiMohri IkukoKagitani-Shimono KurikoOzono KeiichiUrade YoshihiroTaniike Masako<p>Abstract</p> <p>Background</p> <p>Twitcher mouse (<it>twi/twi</it>) is an authentic murine model of Krabbe's disease. Accumulation of psychosine, resulting in apoptosis of oligodendrocytes and subsequent demyelination, is a cardinal event to the pathogenesis of this disease. Moreover, recruitment of inflammatory cells plays a significant role in the pathological process in the <it>twi/twi </it>central and peripheral nervous systems. In this study, we investigated the 1) the relationship between tumor necrosis factor-α (TNFα), pro-inflammatory cytokine, and the progression of this disease and 2) effect of the anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor.</p> <p>Methods</p> <p>We quantified the expression level of TNFα and TNF-receptor mRNA in <it>twi/twi </it>using semi-quantitative RT-PCR. The relationship between TNFα expression, apoptosis of oligodendrocytes and demyelination was studied with immunohistochemistry and TUNEL method. We then treated <it>twi/twi </it>with a daily intraperitoneal injection of ibudilast (10 mg/kg), which suppress TNFα production in the brain.</p> <p>Results</p> <p>We found that TNFα-immunoreactive microglia/macrophages appeared in the <it>twi/twi </it>brain and that the mRNA levels of TNFα and TNF-receptor 1 was increased with the progression of demyelination. The distribution profile of TNFα-immunoreactive microglia/macrophages overlapped that of TUNEL-positive oligodendrocytes in the <it>twi/twi </it>brain. When <it>twi/twi </it>was treated with ibudilast from PND30, the number of oligodendrocytes undergoing apoptosis was markedly reduced and demyelination was milder. Obvious improvement of clinical symptom was noted in two of five. The failure of constant clinical improvement by ibudilast may result from hepatotoxicity and/or the inhibition of proliferation of NG2-positive oligodendrocyte precursors.</p> <p>Conclusion</p> <p>We conclude that anti-inflammatory therapy by a phosphodiesterase inhibitor can be considered as a novel alternative therapy for Krabbe's disease.</p>http://www.jneuroinflammation.com/content/2/1/10
spellingShingle Suzuki Kinuko
Fujitani Yasushi
Mohri Ikuko
Kagitani-Shimono Kuriko
Ozono Keiichi
Urade Yoshihiro
Taniike Masako
Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model
Journal of Neuroinflammation
title Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model
title_full Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model
title_fullStr Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model
title_full_unstemmed Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model
title_short Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model
title_sort anti inflammatory therapy by ibudilast a phosphodiesterase inhibitor in demyelination of twitcher a genetic demyelination model
url http://www.jneuroinflammation.com/content/2/1/10
work_keys_str_mv AT suzukikinuko antiinflammatorytherapybyibudilastaphosphodiesteraseinhibitorindemyelinationoftwitcherageneticdemyelinationmodel
AT fujitaniyasushi antiinflammatorytherapybyibudilastaphosphodiesteraseinhibitorindemyelinationoftwitcherageneticdemyelinationmodel
AT mohriikuko antiinflammatorytherapybyibudilastaphosphodiesteraseinhibitorindemyelinationoftwitcherageneticdemyelinationmodel
AT kagitanishimonokuriko antiinflammatorytherapybyibudilastaphosphodiesteraseinhibitorindemyelinationoftwitcherageneticdemyelinationmodel
AT ozonokeiichi antiinflammatorytherapybyibudilastaphosphodiesteraseinhibitorindemyelinationoftwitcherageneticdemyelinationmodel
AT uradeyoshihiro antiinflammatorytherapybyibudilastaphosphodiesteraseinhibitorindemyelinationoftwitcherageneticdemyelinationmodel
AT taniikemasako antiinflammatorytherapybyibudilastaphosphodiesteraseinhibitorindemyelinationoftwitcherageneticdemyelinationmodel